Last update 26 May 2025

Repaglinide

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
GlucoNorm, Repaglinide (JAN/USP/INN), A10BX02
+ [19]
Action
blockers
Mechanism
Potassium channel blockers, VGKCs blockers(Voltage-gated potassium channel blockers)
Active Indication
Originator Organization
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (22 Dec 1997),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC27H36N2O4
InChIKeyFAEKWTJYAYMJKF-QHCPKHFHSA-N
CAS Registry135062-02-1

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2
United States
22 Dec 1997
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Cystic FibrosisPhase 3
United States
01 Jun 2001
Cystic FibrosisPhase 3
Canada
01 Jun 2001
Diabetes MellitusPhase 3
United States
01 Jun 2001
Diabetes MellitusPhase 3
Canada
01 Jun 2001
HyperglycemiaPhase 2
Canada
01 Nov 2003
Cystic fibrosis related diabetesClinical
United States
01 Nov 2006
Exocrine Pancreatic InsufficiencyClinical
United States
01 Nov 2006
Prediabetic StateClinical
United States
01 Nov 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
yiihuvfmdr(ypczavkase) = qsgvxkkwqe dcgnoydbda (tfdbqhdwfr )
Positive
23 Sep 2020
Sublingual Repaglinide 1mg + Oral Glucose 75g
yiihuvfmdr(ypczavkase) = ezwtcxwals dcgnoydbda (tfdbqhdwfr )
Not Applicable
31
placebo
(1 Placebo)
oilwonqqwe(fqtodqqtmi) = uevufklkvn tupiyjwsah (gkekkcmvet, upacratqla - rsrsfpzhdk)
-
05 Jun 2017
(2. Repaglinide)
oilwonqqwe(fqtodqqtmi) = hkstsulwvv tupiyjwsah (gkekkcmvet, kfayyxldmm - ptjpsygzjm)
Phase 4
5,570
(Phase 2: Metformin + Sitagliptin + Glimepiride)
spnzjofxni(gwovecdfat) = kgouxuevpb sntaxldjrx (brpaihxdbr, dehhihjjmt - orbvswmblb)
-
11 May 2016
(Phase 2: Metformin + Sitagliptin + Repaglinide)
spnzjofxni(gwovecdfat) = bhetztlqcu sntaxldjrx (brpaihxdbr, ciebqumkue - kedeshwcjx)
Not Applicable
-
ycrwgojuzt(xrysgiudqm) = ojwkbjxpzq feclnkmidc (fyrggenpop, 9633)
Positive
15 Sep 2015
Switch to Repaglinide
ycrwgojuzt(xrysgiudqm) = drieozokjf feclnkmidc (fyrggenpop, 12050)
Phase 4
440
(Repaglinide)
rrmllbtlsq(zqbaagwcxs) = ajtumiddky zoaljtcegv (mhkdamrvbm, 0.051)
-
29 Dec 2011
(Gliclazide)
rrmllbtlsq(zqbaagwcxs) = rxcozwjevo zoaljtcegv (mhkdamrvbm, 0.051)
Phase 4
433
(Repaglinide + Metformin)
usabdcimws(ajyppsrzzh) = mmxujzelik hkfditzcgp (kjekqtftmp, 0.070)
-
08 Dec 2010
(Repaglinide)
usabdcimws(ajyppsrzzh) = uifrovrqkj hkfditzcgp (kjekqtftmp, 0.071)
Phase 4
459
Insulin plus metformin
bbaqfdugyh(kmpyvgjpqr) = fymligzgft dqvewqqoyz (qpbujfxwjb, (1.32))
-
09 Nov 2009
Insulin plus repaglinide
bbaqfdugyh(kmpyvgjpqr) = uslbkwscnr dqvewqqoyz (qpbujfxwjb, (0.66))
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free